OTC Pharmaceuticals - Nordics

  • Nordics
  • Revenue in the OTC Pharmaceuticals market amounts to US$1,546.00m in 2024. The market is expected to grow annually by 3.13% (CAGR 2024-2029).
  • The market's largest segment is the segment Analgesics with a market volume of US$387.50m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$55.12 are generated in 2024.
  • In the OTC Pharmaceuticals market, 17.9% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Nordics is experiencing significant growth and development due to various factors. Customer preferences in the Nordics region are shifting towards self-medication and convenience.

Consumers are increasingly seeking over-the-counter (OTC) pharmaceutical products to treat common ailments and minor health issues. This trend is driven by the desire for quick and easy access to healthcare solutions, as well as the growing awareness of the effectiveness and safety of OTC medications. Trends in the market indicate a strong demand for OTC pharmaceuticals in the Nordics.

The region is witnessing a rise in the availability and variety of OTC products, catering to a wide range of health needs. This includes products for pain relief, cough and cold, digestive health, and skincare. The market is also witnessing an increase in the number of private label brands, offering affordable alternatives to well-known OTC brands.

Local special circumstances in the Nordics contribute to the growth of the OTC Pharmaceuticals market. The region has a well-developed healthcare system, with easy access to pharmacies and healthcare professionals. This enables consumers to seek advice and purchase OTC medications conveniently.

Additionally, the high level of education and awareness among the population further fuels the demand for OTC pharmaceuticals. Underlying macroeconomic factors also play a role in the development of the OTC Pharmaceuticals market in the Nordics. The region has a high disposable income per capita, allowing consumers to afford OTC medications.

Moreover, the aging population in the Nordics is driving the demand for OTC products, as older individuals are more likely to experience chronic health conditions and require self-medication options. In conclusion, the OTC Pharmaceuticals market in the Nordics is experiencing growth and development due to changing customer preferences, increasing availability of OTC products, local special circumstances, and underlying macroeconomic factors. As consumers in the region continue to prioritize self-medication and convenience, the market is expected to witness further expansion in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)